Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141539 |
| CAS No | NA |
| Mol.F. | C14H12FIN4O3 |
| Mol.Wt. | 430.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141540 |
| CAS No | NA |
| Mol.F. | C26H22FIN6O5 |
| Mol.Wt. | 644.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141541 |
| CAS No | NA |
| Mol.F. | C25H22FIN6O4 |
| Mol.Wt. | 616.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141542 |
| CAS No | NA |
| Mol.F. | C21H22N6O5 |
| Mol.Wt. | 438.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141543 |
| CAS No | NA |
| Mol.F. | C25H24FIN6O4 |
| Mol.Wt. | 618.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141544 |
| CAS No | NA |
| Mol.F. | C17H16FIN4O4 |
| Mol.Wt. | 486.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141545 |
| CAS No | NA |
| Mol.F. | C26H23FN6O5 |
| Mol.Wt. | 518.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141546 |
| CAS No | NA |
| Mol.F. | C24H20FIN6O4 |
| Mol.Wt. | 602.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141547 |
| CAS No | NA |
| Mol.F. | C25H23FIN7O5 |
| Mol.Wt. | 647.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141548 |
| CAS No | NA |
| Mol.F. | C10H15N5O |
| Mol.Wt. | 221.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141549 |
| CAS No | NA |
| Mol.F. | C10H13BrN4O |
| Mol.Wt. | 285.1 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141550 |
| CAS No | NA |
| Mol.F. | C26H27N7O4S2 |
| Mol.Wt. | 565.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141551 |
| CAS No | 3035190-56-5 |
| Mol.F. | C21H23N5O3S |
| Mol.Wt. | 425.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141552 |
| CAS No | NA |
| Mol.F. | C17H20N4O3 |
| Mol.Wt. | 328.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141553 |
| CAS No | 3035190-52-1 |
| Mol.F. | C16H19N3O2 |
| Mol.Wt. | 285.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141554 |
| CAS No | 3035190-51-0 |
| Mol.F. | C16H17N3O4 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |